Bayer Pay-For-Delay Deal A Taste Of Post-Actavis Climate
Bayer Corp.'s $74 million payout last week to escape a consumer class action over pay-for-delay deals with generic-drug makers will likely be the first of many settlements to come, experts say,...To view the full article, register now.
Already a subscriber? Click here to view full article